TradeTrade
Jump to any asset 849 assets, updated daily

As of September 15, 2026, iShares U.S. Medical Devices ETF (IHI) trades at $51.86. RSI at 23 is in oversold territory, and the price is below its 50-day average of $53.14.

iShares U.S. Medical Devices ETF (IHI)

iShares U.S. Medical Devices ETF NYSE

$51.86 0.9800 (1.93%)
At close: Sep 14, 4:00 PM EDT
AI Analyst Consensus
Sell
25 / 100
The iShares U.S. Medical Devices ETF (IHI) is currently experiencing a pronounced downtrend, trading below its 50-day and 200-day moving averages ($53.14 and $55.30). The fund's recent performance, as indicated by its Year-to-Date return of -11.36%, reflects weakness within the medical devices sector. Despite this, the ETF's overview highlights its focus on U.S. companies involved in the manufacturing and distribution of medical equipment, a segment that supports critical aspects of healthcare delivery. The fund's strategy aims to provide targeted exposure to this specialized area of the healthcare industry.

IHI Price Analysis

Market Metrics

Open
$51.59
Day Range
$51.56 to $52.05
Prev Close
$50.88
Volume
2.50M
52-Week Range
$47.37 to $64.71

IHI Fund Facts

iShares U.S. Medical Devices ETF is an exchange-traded fund that seeks to track the Dow Jones U.S. Select Medical Equipment Index, giving investors broad exposure to U.S. companies involved in the medical devices sector. The fund focuses on manufacturers and distributors of medical equipment used in diagnostics, imaging, patient monitoring, surgical procedures, and therapeutic care, including products such as pacemakers, prosthetics, MRI scanners, X-ray machines, and related non-disposable devices.

Issuer
iShares
Category
Health
Inception
May 1, 2006
Expense ratio
0.37%
Net assets
$3.47B
NAV
$51.46
Distribution yield
0.44%
YTD return
-11.36%
Turnover
12.00%

Sector weights

Healthcare 100.0%

Trailing returns vs category

Period IHI Category
YTD -11.36% -2.39%
1 month 4.72% 1.70%
3 months 12.41% -3.03%
1 year -11.16% 21.31%
3 years 2.01% 6.58%
5 years -3.03% 1.49%
10 years 9.13% 8.56%

Fund reference data as of Sep 15, 2026. Expense ratio and net assets are reported by the fund; returns are total returns and can differ from price change.

IHI Analysis

AI Technical Analysis Sell
As of September 15, 2026, IHI is trading below its 50-day SMA of $53.14 and its 200-day SMA of $55.30. The 20-day EMA is at $53.32, also above the current price of $51.86. The Relative Strength Index (RSI) is at 22.76, signaling oversold conditions. The MACD is at -0.63, indicating bearish momentum. The Stochastic indicator is at 25.42, further reinforcing the oversold sentiment. Support is indicated by the current price relative to the SMAs, while resistance is seen at the 50-day and 200-day moving averages.
ProTips
  • Monitor the 50-day and 200-day SMAs for potential trend reversals.
  • Consider the sector's overall performance relative to the broader market for macro context.
  • Evaluate the performance of top underlying holdings for insights into sector health.
Market Outlook
The outlook for IHI is bearish in the short to medium term, given its current technical positioning. The ETF is trading below critical moving averages, and momentum indicators suggest further downside is possible before any potential oversold bounce. A sustained move above the 50-day SMA would be required to signal a shift in the trend. The sector's recent underperformance compared to its category adds to the negative sentiment. Any positive developments in the broader healthcare sector or specific catalysts for medical device companies could alter this outlook.

Market Correlations

How this etf moves relative to other assets

Based on 1 year of daily price data. Correlations may vary over different time periods.

S&P 500 (SPY) +0.54
Moderate correlation
Nasdaq 100 (QQQ) +0.38
Weak correlation
Bitcoin (BTC) +0.00
Weak correlation
Gold (XAU) +0.08
Weak correlation
Check Custom Correlation

How does any other asset move with IHI? One year of daily closes, Pearson correlation.

Try

Key Statistics

Yield 0.47%
Day High $52.05
Day Low $51.56
52 Week High 64.71
52 Week Low 47.37
IHI's portfolio is heavily concentrated in the Healthcare sector, with 99.87% allocated to stocks. The fund tracks the Dow Jones U.S. Select Medical Equipment Index, providing exposure to companies involved in the manufacturing and distribution of medical devices. The expense ratio is 0.37%, costing $37.00 per $10,000 invested, with net assets totaling $3.47 billion.

Earnings & Growth Analysis

Its underlying holdings are in the medical devices sector. The sector's performance, as reflected in IHI's YTD return of -11.36%, suggests that aggregate earnings trends for these companies may be under pressure or that the market is anticipating slower growth. The fund's focus on established healthcare technology and equipment companies implies a reliance on consistent demand for diagnostic and therapeutic equipment, which can be influenced by broader economic conditions and healthcare spending trends.

Key Risks

The primary risk for IHI is its high concentration within the medical devices sector, making it susceptible to sector-specific downturns or regulatory changes impacting medical equipment manufacturers. The current bearish technical trend, with the price below key moving averages and oversold RSI, indicates significant short-term downside risk. Also, the fund's trailing 1-year return of -11.16% compared to its category's 21.31% return highlights underperformance that could persist.

Technical Indicators i

RSI (14) 22.76
MACD -0.63
SMA 50 53.14
SMA 200 55.30
Technical Rating Bearish
RSI
Oversold
SMA Cross
Bearish
Price vs SMA
Bearish
MACD
Bearish
Moving averages show a lagging Death Cross (50-day: $53.14, 200-day: $55.30), price is trading below the 50-day SMA, RSI at 22.8 suggests oversold conditions; potential bounce setup.

IHI Trade Plans

Specific entry, exit, and risk management levels

Select Your Trade Bias
Risk Tolerance
Conservative 2% Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →

Short entry pick an entry style

Conservative
$52.90
2% above current price
Lower risk, wait for rally
Aggressive
$51.86
Short at current price
Higher risk, chasing the move

Risk Management

STOP LOSS
$54.64
MAX LOSS
-3.3%
Volatility-Adjusted Stop Loss
Calculated based on RSI (22.8) and current market volatility

Profit Targets (Based on Conservative Entry)

TARGET 1
$50.25
-5% (Conservative)
-3.1% (Aggressive)
TARGET 2
$47.61
-10% (Conservative)
-8.2% (Aggressive)
TARGET 3
$44.96
-15% (Conservative)
-13.3% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
ETF Investment Disclaimer
This AI-generated analysis of IHI is for educational purposes only and does not constitute investment advice. ETFs are subject to market risk including possible loss of principal. Performance depends on the underlying index or assets tracked. Read the fund prospectus before investing. Past performance does not guarantee future results. Generated on September 15, 2026.

Growth of $10,000

A $10,000 investment in IHI in September 2016 would be worth about $21,866 today, compared with about $35,344 for the same investment in the S&P 500 benchmark.

Compare with Another Ticker

Monte Carlo Projection (10yr)

CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in IHI today could grow to about $20,965 by 2036 in the base case, with a bull case near $47,420 and a bear case around $9,269. Projections are statistical simulations, not guarantees.

IHI ETF Price Prediction: 2030

CleaRank's simulation projects a price near $69.73 for IHI by 2030 in the base case, from $51.86 today (1.3x over 4 years). The downside path ends near $41.61. These are outcomes of a Monte Carlo simulation run on IHI's historical return distribution, not price targets, and they assume no dividends are reinvested.

IHI simulated price paths by year
Year Downside (10th pct) Base case Upside (90th pct)
2027 $43.14 $55.84 $72.29
2028 $41.74 $60.14 $86.63
2029 $41.41 $64.76 $101
2030 $41.61 $69.73 $117
2031 $42.16 $75.09 $134
2032 $42.97 $80.86 $152
2033 $43.98 $87.07 $172
2034 $45.18 $93.76 $195
2035 $46.55 $101 $219
2036 $48.07 $109 $246

Method: 10,000 simulated price paths using IHI's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.

People Also Watch

Frequently Asked Questions

What is the expense ratio for the iShares U.S. Medical Devices ETF (IHI)?
The expense ratio for IHI is 0.37%, which translates to a cost of $37.00 per $10,000 invested over a year. The fund has net assets of $3.47 billion.
What sectors does the iShares U.S. Medical Devices ETF (IHI) primarily hold?
IHI is heavily concentrated in the Healthcare sector, with 99.87% of its assets allocated to stocks within this industry. It specifically focuses on companies involved in the manufacturing and distribution of medical equipment.
How has the iShares U.S. Medical Devices ETF (IHI) performed against its category over the past year?
Over the past year, IHI has returned -11.16%, significantly underperforming its category's return of 21.31%.
What are the key technical levels for IHI?
IHI is currently trading below its 50-day SMA of $53.14 and its 200-day SMA of $55.30. The RSI is at 22.76, indicating oversold conditions.
What is the iShares U.S. Medical Devices ETF (IHI) price prediction for 2030?
Based on Monte Carlo simulations, the base case price prediction for IHI in 2030 is $69.73, with a downside scenario of $41.61. These are statistical simulation outcomes, not price targets or guarantees.
What is the dividend yield for IHI?
The dividend yield for IHI is 0.47%.
What is the overview of the iShares U.S. Medical Devices ETF (IHI)?
IHI seeks to track the Dow Jones U.S. Select Medical Equipment Index, providing broad exposure to U.S. companies in the medical devices sector. It focuses on manufacturers and distributors of medical equipment used in diagnostics, imaging, and patient care.

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. The ETF analysis and AI-generated insights presented for IHI are for educational and informational purposes only and do not constitute financial advice, investment recommendations, or an offer to buy or sell any securities. ETFs are subject to market risk, including the possible loss of principal. ETF performance depends on the underlying index or assets it tracks, and past performance does not guarantee future results. Expense ratios, tracking error, and liquidity vary by fund. All trade setups and performance metrics shown are hypothetical, hindsight-based, and simulated. Market data is provided "as-is" and may be delayed by 15 minutes or more. Investors should read the fund prospectus carefully before investing. Consult a qualified financial advisor for personalized guidance. Analysis generated on September 15, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.